The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tiziana Life Science To Cancel AIM Trading Ahead Of Move To Bermuda

Mon, 13th Jan 2020 11:07

(Alliance News) - Tiziana Life Science PLC on Monday said it intends to cancel its shares from trading on the London Stock Exchange ahead of its plan to redomicile in Bermuda.

The biotechnology company announced an intended redomicile from London to Bermuda by the second quarter of 2020. It is therefore seeking shareholder consent for its shares to be cancelled from trading when the move occurs.

Tiziana says it intends drop its shares currently traded as American Depositary Receipts on Nasdaq in New York but have its Bermuda common shares traded on Nasdaq instead.

The company's shares on AIM were 30% lower at 36.10 pence each on Monday morning in London.

By Ife Taiwo; ifetaiwo@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.